LIFECORE BIOMEDICAL, INC. Interest Income Financing Receivable Before Allowance For Credit Loss
LIFECORE BIOMEDICAL, INC. (LFCR) reported Interest Income Financing Receivable Before Allowance For Credit Loss of $99.00 thousand for the 7-month period ending 2025-12-31, per its 10-KT filed 2026-03-16.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss · last filed 2026-03-16
- LIFECORE BIOMEDICAL, INC. interest income financing receivable before allowance for credit loss for the quarter ending 2025-05-25 was $100.00K.
- LIFECORE BIOMEDICAL, INC. interest income financing receivable before allowance for credit loss for fiscal 2025 was $205.00K.
| Period end | Interest Income Financing Receivable Before Allowance For Credit Loss 3 month | Interest Income Financing Receivable Before Allowance For Credit Loss 7 month | Interest Income Financing Receivable Before Allowance For Credit Loss 9 month | Interest Income Financing Receivable Before Allowance For Credit Loss 12 month |
|---|---|---|---|---|
| 2025-12-31 | $99.00K 10-KT · filed 2026-03-16 | |||
| 2025-05-25 | $100.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | $205.00K 10-KT · filed 2026-03-16 | ||
| 2025-02-23 | $105.00K 10-Q · filed 2025-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |